18 May 2021
Complete 2-year follow-up from the Evolut low risk trial
London Studio
Studio discussant:
B. Prendergast
Speaker:
J. Forrest
Summary
This session was originally presented during EuroPCR 2021.
Learning Objectives
- To know the 2-year results from the Evolut Low Risk Trial
- To learn the predicted vs the actual outcomes of this study
